Clinical trials - charts and statistics
Sept 1, 1999 update
| VECTOR | PROTOCOLS | PATIENTS | ||
|---|---|---|---|---|
| NUMBER | % | NUMBER | % | |
| Adeno-Associated Virus | 3 | 0,8 | 36 | 1,1 |
| Adenovirus | 71 | 17,9 | 437 | 13,3 |
| Electroporation | 2 | 0,5 | 20 | 0,6 |
| Gene gun | 4 | 1 | 35 | 1,1 |
| Herpesvirus | 1 | 0,3 | 0 | 0 |
| Lipofection | 73 | 18,4 | 735 | 22,4 |
| Lipofection / AAV | 2 | 0,5 | 0 | 0 |
| Lipofection / Adenovirus | 1 | 0,3 | 3 | 0,1 |
| Naked DNA | 16 | 4 | 69 | 2,1 |
| Poxvirus | 26 | 6,6 | 130 | 4 |
| Retroviral vector producing cells | 20 | 5,1 | 408 | 12,4 |
| Retrovirus | 158 | 39,9 | 1217 | 37,1 |
| Retrovirus / Gene gun | 1 | 0,3 | 6 | 0,2 |
| RNA transfer | 1 | 0,3 | 30 | 0,9 |
| Other transfections | 7 | 1,8 | 101 | 3,1 |
| N/C | 9 | 2,3 | 51 | 1,6 |
| AAV | 1 | 0,3 | 0 | 0 |
| Total | 396 |
|
3278 | 100 |